{{distinguish|甲狀腺腫}}
{{medical}}
'''甲狀腺腫瘤'''（Thyroid neoplasm）是生長於甲狀腺的腫瘤，可分為[[良性腫瘤|良性腫瘤]]（如[[甲狀腺腺瘤|甲狀腺腺瘤]]），以及[[惡性腫瘤|惡性腫瘤]]（如[[甲狀腺癌|甲狀腺癌]]）<ref name=Kumar20> Chapter 20 in: {{cite book |author=Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson |title=Robbins Basic Pathology|publisher=Saunders |location=Philadelphia |year= |pages= |isbn=1-4160-2973-7 |oclc= |doi=}} 8th edition. </ref><ref name=hu>Hu MI, Vassilopoulou-Sellin R, Lustig R, Lamont JP. [http://www.cancernetwork.com/cancer-management-11/chapter05/article/10165/1402668 "Thyroid and Parathyroid Cancers"] in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) [http://www.cancernetwork.com/cancer-management-11/ Cancer Management: A Multidisciplinary Approach]. 11 ed. 2008.</ref>。大多數患者在25到65歲時初次罹患此病，而且女性較男性罹病機率為高。<ref name=na>National Cancer Institute. ''What You Need to Know About Thyroid Cancer'' National Cancer Institute, 2010.Print</ref>

==分類==
===良性腫瘤===
[[甲狀腺腺瘤|甲狀腺腺瘤]]為良性腫瘤，80%的成人會在70歲左右得到甲狀腺結節，而大約90%~95%為良性<ref name=na/><ref name=hu/><ref>Al-Zaher N, Al-Salam S, El Teraifi H. Thyroid carcinoma in the United Arab Emirates: perspectives and experience of a tertiary care hospital. Hematol Oncol Stem Cell Ther 2008;1:14-21. [http://www.hemoncstem.net "Hematology/Oncology and Stem Cell Therapy"]</ref>
===惡性腫瘤===
{{main|甲狀腺癌}}
[[甲狀腺癌|甲狀腺癌]]主要分為[[乳突性甲狀腺癌|乳突性]]、[[濾泡性甲狀腺癌|濾泡性]]、[[髓樣甲狀腺癌|髓樣]]以及[[退行性甲狀腺癌|退行性甲狀腺癌]]<ref name=hu>Hu MI, Vassilopoulou-Sellin R, Lustig R, Lamont JP. [http://www.cancernetwork.com/cancer-management-11/chapter05/article/10165/1402668 "Thyroid and Parathyroid Cancers"] in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) [http://www.cancernetwork.com/cancer-management-11/ Cancer Management: A Multidisciplinary Approach]. 11 ed. 2008.</ref> 大多數患者在25到65歲時初次罹患此病。<ref name=hu/><ref>Al-Zaher N, Al-Salam S, El Teraifi H. Thyroid carcinoma in the United Arab Emirates: perspectives and experience of a tertiary care hospital. Hematol Oncol Stem Cell Ther 2008;1:14-21. [http://www.hemoncstem.net "Hematology/Oncology and Stem Cell Therapy"]</ref>

80%的甲狀腺癌為乳突性，15%為濾泡性，3%為髓樣。此三者發育緩慢，若及早治療有機會痊癒。真正致命性的是退行性的甲狀腺癌，發育極快且難以控制。
<ref name=na/>

其他種類的甲狀腺癌包括[[甲狀腺淋巴癌|甲狀腺淋巴癌]]、[[甲狀腺肉癌|甲狀腺肉癌]]、[[甲狀腺平滑肌癌|甲狀腺平滑肌癌]]、[[畸胎瘤|畸胎瘤]]、[[扁平上皮癌|扁平上皮癌]]和其他罕見癌症。<ref>{{cite book |author=DeLellis R.A., Lloyd R.V., Heitz P.U., Eng C. (Eds.)|title=World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs|year=2004 |publisher=IARC Press |location=Lyon, France |pages=94-123 |isbn=92-832-2416-7}}</ref>

==診斷及治療==
{{See|甲狀腺結節}}
[[甲狀腺結節|甲狀腺結節]]是甲狀腺腫瘤的主要表現方式，如果發現甲狀腺結節，可以針吸細胞活檢術（Fine needle aspiration, FNA）取出檢體細胞進行組織培養，以辨別其為惡性腫瘤與否。FNA為取檢體最經濟的方式。<ref name=na/><ref>Schmitt, Fernando. "Thyroid Cytology: Is FNA Still The Best Diagnostic Approach?"''International Journal of Surgical Pathology'',June 2010,vol 18, p.201-204.</ref> 

由於癌化的甲狀腺細胞也會吸收[[碘|碘]]，因此可以放射性的[[碘-131|碘-131]]殺死癌細胞，以治療乳突形、濾泡型及髓樣甲狀腺癌。<ref name=hu/><ref name=hu/>

甲狀腺結節在20歲以後發生為惡性腫瘤的機會較大，因此需要特別關注。

治療需視患者的體質及年齡，以及會擴散與否<ref name=hu/>。另外假設良性甲狀腺瘤影響到吞嚥、說話和呼吸，仍須酌以切除。

有時候部分移除甲狀腺會造成[[甲狀腺機能低下|甲狀腺機能低下]]。  

若為惡性腫瘤或有[[逆行性生長|逆行性生長]]的跡象，則予以切除。<ref name=hu/>切除甲狀腺為一中等風險的手術，可能會導致併發症。切除甲狀腺的患者必需服用[[甲狀腺素|甲狀腺素]]以維持身體機能。

== 參見 ==
* [[輻射汙染|輻射汙染]]（甲狀腺癌的其中一個原因）

==註釋==
{{reflist|2}}

==外部連結==
* [https://web.archive.org/web/20071212173802/http://www.thyroidtrials.org/ Thyroid Cancer Clinical Trials Page] of the American Thyroid Association
* [http://www.nucmedinfo.com/Pages/thyroid.html Nuclear Medicine Information =– Thyroid Diseases]
* [http://www.cancer.gov/cancertopics/types/thyroid Thyroid Cancer]- National Cancer Institute
* [http://patients.uptodate.com/topic.asp?file=endocrin/11828 Diagnostic patient information]

[[Category:甲狀腺疾病|Category:甲狀腺疾病]]